Researchers have developed AiCE, an AI-informed strategy that integrates structural and evolutionary constraints for enhanced protein engineering efficiency. This approach accelerates protein evolution without requiring specialized AI model training, representing a significant advancement in the design of therapeutics and other biologics. Meanwhile, platforms such as Viome partnering with Microsoft demonstrate the application of AI-powered RNA-based molecular diagnostics for personalized preventive healthcare, signaling broad integration of AI and biotech.